Amanda Saracino

557 total citations
17 papers, 358 citations indexed

About

Amanda Saracino is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology. According to data from OpenAlex, Amanda Saracino has authored 17 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 6 papers in Dermatology and 5 papers in Rheumatology. Recurrent topics in Amanda Saracino's work include Systemic Lupus Erythematosus Research (5 papers), Systemic Sclerosis and Related Diseases (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Amanda Saracino is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Systemic Sclerosis and Related Diseases (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). Amanda Saracino collaborates with scholars based in Australia, United Kingdom and Germany. Amanda Saracino's co-authors include Mandana Nikpour, Christopher P. Denton, Catherine H. Orteu, Thomas Krieg, Rebekka Jerjen, Danny Liew, Alvin H Chong, David Isenberg, Jessica Fairley and Shereen Oon and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and Seminars in Arthritis and Rheumatism.

In The Last Decade

Amanda Saracino

16 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Saracino Australia 11 136 119 109 99 75 17 358
Yi Chun Lai United States 12 66 0.5× 126 1.1× 32 0.3× 37 0.4× 56 0.7× 28 329
Bilge Bülbül Şen Türkiye 10 55 0.4× 106 0.9× 71 0.7× 50 0.5× 86 1.1× 25 333
Russell-Jones United Kingdom 8 87 0.6× 101 0.8× 68 0.6× 53 0.5× 33 0.4× 11 245
S. Toquet France 9 71 0.5× 23 0.2× 149 1.4× 99 1.0× 88 1.2× 16 315
Raffaele Pellerito Italy 10 162 1.2× 43 0.4× 172 1.6× 101 1.0× 86 1.1× 17 376
Camilla Dalle Vedove Italy 7 69 0.5× 120 1.0× 184 1.7× 49 0.5× 121 1.6× 9 374
Paola Coral-Alvarado Colombia 8 157 1.2× 48 0.4× 81 0.7× 55 0.6× 57 0.8× 15 288
Marion Mehrenberger France 11 205 1.5× 89 0.7× 73 0.7× 110 1.1× 126 1.7× 17 451
Roberto Bortolotti Italy 10 33 0.2× 15 0.1× 59 0.5× 82 0.8× 61 0.8× 28 338
Elżbieta Kamińska Canada 8 331 2.4× 147 1.2× 62 0.6× 78 0.8× 114 1.5× 14 464

Countries citing papers authored by Amanda Saracino

Since Specialization
Citations

This map shows the geographic impact of Amanda Saracino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Saracino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Saracino more than expected).

Fields of papers citing papers by Amanda Saracino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Saracino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Saracino. The network helps show where Amanda Saracino may publish in the future.

Co-authorship network of co-authors of Amanda Saracino

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Saracino. A scholar is included among the top collaborators of Amanda Saracino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Saracino. Amanda Saracino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wada, M., et al.. (2024). Atypical morphoea, a herald of two malignancies: Lung adenocarcinoma and a neuroendocrine tumour. Journal of Scleroderma and Related Disorders. 9(3). NP1–NP4.
2.
Saracino, Amanda, et al.. (2023). Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies. Archives of Dermatological Research. 315(7). 2035–2056. 2 indexed citations
3.
Jerjen, Rebekka, Mandana Nikpour, Thomas Krieg, Christopher P. Denton, & Amanda Saracino. (2022). Systemic sclerosis in adults. Part I: Clinical features and pathogenesis. Journal of the American Academy of Dermatology. 87(5). 937–954. 69 indexed citations
4.
Fairley, Jessica, Mandana Nikpour, Heather G. Mack, et al.. (2022). How toxic is an old friend? A review of the safety of hydroxychloroquine in clinical practice. Internal Medicine Journal. 53(3). 311–317. 13 indexed citations
5.
Jerjen, Rebekka, Mandana Nikpour, Thomas Krieg, Christopher P. Denton, & Amanda Saracino. (2022). Systemic sclerosis in adults. Part II: management and therapeutics. Journal of the American Academy of Dermatology. 87(5). 957–978. 14 indexed citations
6.
Saracino, Amanda, et al.. (2020). Comparing paediatric- and adult-onset linear morphoea in a large tertiary-referral scleroderma centre. Journal of Scleroderma and Related Disorders. 6(1). 102–108. 5 indexed citations
7.
Fairley, Jessica, Shereen Oon, Amanda Saracino, & Mandana Nikpour. (2019). Management of cutaneous manifestations of lupus erythematosus: A systematic review. Seminars in Arthritis and Rheumatism. 50(1). 95–127. 37 indexed citations
8.
Mar, Adrian, et al.. (2019). Hydroxychloroquine in dermatology: New perspectives on an old drug. Australasian Journal of Dermatology. 61(2). e150–e157. 20 indexed citations
9.
Isenberg, David, et al.. (2018). Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus. JAMA Dermatology. 154(12). 1432–1432. 46 indexed citations
10.
Saracino, Amanda, Christopher P. Denton, & Catherine H. Orteu. (2016). The molecular pathogenesis of morphoea: from genetics to future treatment targets. British Journal of Dermatology. 177(1). 34–46. 34 indexed citations
11.
Saracino, Amanda & Catherine H. Orteu. (2016). Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treated with fumaric acid esters. British Journal of Dermatology. 176(2). 472–480. 17 indexed citations
12.
Saracino, Amanda, et al.. (2012). Intralymphatic granulomas in lymphoedema secondary to anogenital granulomatosis. Australasian Journal of Dermatology. 54(3). e59–e61. 6 indexed citations
13.
Saracino, Amanda, et al.. (2011). Pyoderma gangrenosum requiring inpatient management: A report of 26 cases with follow up. Australasian Journal of Dermatology. 52(3). 218–221. 60 indexed citations
14.
Saracino, Amanda, Tracey Weiland, Brian Jolly, & Andrew W Dent. (2010). Verbal dyspnoea score predicts emergency department departure status in patients with shortness of breath. Emergency Medicine Australasia. 22(1). 21–29. 15 indexed citations
15.
Saracino, Amanda, Tracey Weiland, Andrew W Dent, & Brian Jolly. (2008). Validation of a Verbal Rating Scale for Breathlessness Amongst Patients Referred for Cardiac Stress Tests. Heart Lung and Circulation. 17(4). 305–312. 4 indexed citations
16.
Saracino, Amanda, Tracey Weiland, Andrew W Dent, & Brian Jolly. (2008). Validation of a verbal dyspnoea rating scale in the emergency department. Emergency Medicine Australasia. 20(6). 475–481. 11 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026